The $1.5 billion project builds on more than $3 billion the global biopharmaceutical company has already invested in its United States operations since 2018 and is expected to create at least 300 new jobs alongside hundreds of construction roles. …
CSL expands US manufacturing with $1.5bn investment to boost plasma therapy production
March 10, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
Alterity Therapeutics updates investors on key meeting with US regulator
March 30, 2026 - - Australian Biotech -
Aroa Biosurgery reports promising trial milestone for advanced wound treatment
March 30, 2026 - - Australian Biotech -
Genetic Signatures reshapes its business to cut costs and drive growth
March 30, 2026 - -
Cynata reaches crucial milestone as Phase 2 trial moves toward results
March 30, 2026 - - Australian Biotech -
AI meets oncology as Algorae advances drug discovery collaboration
March 30, 2026 - - Australian Biotech -
The minister was subtle, but read between the lines, and the message could hardly be clearer
March 30, 2026 - - Latest News -
Government expands access to cancer therapy but holds short on pan-tumour listing
March 30, 2026 - - Latest News